[go: up one dir, main page]

FI911666A7 - Karbapenemfoereningar. - Google Patents

Karbapenemfoereningar. Download PDF

Info

Publication number
FI911666A7
FI911666A7 FI911666A FI911666A FI911666A7 FI 911666 A7 FI911666 A7 FI 911666A7 FI 911666 A FI911666 A FI 911666A FI 911666 A FI911666 A FI 911666A FI 911666 A7 FI911666 A7 FI 911666A7
Authority
FI
Finland
Prior art keywords
carbapenem compounds
carbapenem
compounds
Prior art date
Application number
FI911666A
Other languages
English (en)
Finnish (fi)
Other versions
FI911666A0 (fi
Inventor
Scott Louis Dax
Dennis Dalton Keith
Pamela Loreen Rossman
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI911666A0 publication Critical patent/FI911666A0/fi
Publication of FI911666A7 publication Critical patent/FI911666A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI911666A 1990-04-09 1991-04-08 Karbapenemfoereningar. FI911666A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50613590A 1990-04-09 1990-04-09

Publications (2)

Publication Number Publication Date
FI911666A0 FI911666A0 (fi) 1991-04-08
FI911666A7 true FI911666A7 (fi) 1991-10-10

Family

ID=24013339

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911666A FI911666A7 (fi) 1990-04-09 1991-04-08 Karbapenemfoereningar.

Country Status (17)

Country Link
EP (1) EP0451764A1 (hu)
JP (1) JPH04234884A (hu)
AU (1) AU7420591A (hu)
BR (1) BR9101418A (hu)
CA (1) CA2039987A1 (hu)
CS (1) CS94391A2 (hu)
FI (1) FI911666A7 (hu)
HU (1) HUT57769A (hu)
IE (1) IE911161A1 (hu)
IL (1) IL97797A0 (hu)
MC (1) MC2262A1 (hu)
MX (1) MX25231A (hu)
NO (1) NO911357L (hu)
PT (1) PT97287A (hu)
TW (1) TW216420B (hu)
YU (1) YU62991A (hu)
ZA (1) ZA912279B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
ATE193890T1 (de) * 1990-04-18 2000-06-15 Procter & Gamble Pharma Antimikrobielle chinolonyl-lactame
HUT67423A (en) * 1991-10-01 1995-04-28 Procter & Gamble Pharma Process for the production of antimicrobal compounds containing quinolone moiety and beta-lactam moiety
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
DE4234330A1 (de) * 1992-10-12 1994-04-14 Bayer Ag Chinoloncarbonsäuren
MX9700872A (es) * 1994-08-02 1997-05-31 Procter & Gamble Procedimiento para producir antimicrobianos de quinolonil-lactama y compuestos intermediarios novedosos.
KR100242355B1 (ko) * 1994-08-02 2000-03-02 데이비드 엠 모이어 항미생물 화합물의 제조 방법
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
US5973142A (en) * 1997-01-21 1999-10-26 Yasuda; Nobuyoshi Process for synthesizing carbapenem intermediates
DE69817167D1 (de) * 1997-01-21 2003-09-18 Merck & Co Inc Verfahren zur herstellung von zwischenprodukten des carbapenems
US6080854A (en) * 1997-08-25 2000-06-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1179675A (en) * 1981-01-30 1984-12-18 Erwin Gotschi 7-oxo-1-azabicyclo ¬3,2,0| heptene-2-derivatives
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
ES2148135T3 (es) * 1988-10-24 2000-10-16 Norwich Eaton Pharma Nuevos esteres antimicrobianos de quinolonil lactamas.
EP0366193A3 (en) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial quinolonyl lactams

Also Published As

Publication number Publication date
IE911161A1 (en) 1991-10-09
NO911357D0 (no) 1991-04-08
JPH04234884A (ja) 1992-08-24
CS94391A2 (en) 1991-11-12
ZA912279B (en) 1992-02-26
PT97287A (pt) 1992-01-31
AU7420591A (en) 1991-10-10
FI911666A0 (fi) 1991-04-08
BR9101418A (pt) 1991-11-26
EP0451764A1 (en) 1991-10-16
HUT57769A (en) 1991-12-30
YU62991A (sh) 1994-04-05
NO911357L (no) 1991-10-10
TW216420B (hu) 1993-11-21
HU911132D0 (en) 1991-10-28
IL97797A0 (en) 1992-06-21
MC2262A1 (fr) 1993-04-26
CA2039987A1 (en) 1991-10-10
MX25231A (es) 1993-10-01

Similar Documents

Publication Publication Date Title
MX9201819A (es) Compuestos benzoheterociclicos.
FI923931A0 (fi) Anordning foer granskning av insidan av en foergrenad roerlinje.
FI911702L (fi) Pollist foer teleteknik.
FI915208A7 (fi) Styrrulle.
FI914228A7 (fi) Azacykliska foereningar.
MX9202978A (es) Compuestos de amino-4-aril-tiazoles.
DE69112037D1 (de) Waferträger.
FI915825L (fi) Heterocykliska foereningar.
DE69111876D1 (de) Ophthalmometer.
NO911357D0 (no) Carbapenem-forbindelser.
FI910750A7 (fi) Heterocykliska foereningar.
DE59104521D1 (de) Polkern.
FI912220A7 (fi) Heterocykliska foereningar.
FI914910L (fi) Heterocykliska foereningar.
EP0668864A4 (en) SUBSTITUTED BIPHENYLMETHYLIMIDAZOPYRIDINE.
DE69100071D1 (de) Kaefigmutter.
MX9202690A (es) Nuevos compuestos de cefem.
DE59105617D1 (de) Phosphorverbindungen.
FI910748A7 (fi) Heterocykliska foereningar.
DE69110728D1 (de) 8-Sulfamylmethylen-2-aminotetraline.
DE59409946D1 (de) Antidröhnmassen.
DE59103525D1 (de) Honmachine.
DE69104797D1 (de) 2-Substituierte-1-Hydroxyindole.
MX9102825A (es) Compuestos sulfurados.
DE59103481D1 (de) o-Aminoazoverbindungen.

Legal Events

Date Code Title Description
FD Application lapsed